Compare MLAB & NMAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLAB | NMAI |
|---|---|---|
| Founded | 1982 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.8M | 440.6M |
| IPO Year | N/A | N/A |
| Metric | MLAB | NMAI |
|---|---|---|
| Price | $93.08 | $13.61 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $94.00 | N/A |
| AVG Volume (30 Days) | ★ 94.2K | 74.8K |
| Earning Date | 02-03-2026 | 01-01-0001 |
| Dividend Yield | 0.70% | ★ 13.14% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.68 | 0.64 |
| Revenue | ★ $247,541,000.00 | N/A |
| Revenue This Year | $4.96 | N/A |
| Revenue Next Year | $4.85 | N/A |
| P/E Ratio | $134.88 | ★ $19.03 |
| Revenue Growth | ★ 4.12 | N/A |
| 52 Week Low | $55.45 | $10.60 |
| 52 Week High | $155.12 | $12.55 |
| Indicator | MLAB | NMAI |
|---|---|---|
| Relative Strength Index (RSI) | 65.05 | 56.31 |
| Support Level | $77.48 | $13.37 |
| Resistance Level | $98.14 | $13.62 |
| Average True Range (ATR) | 3.89 | 0.12 |
| MACD | 0.84 | 0.00 |
| Stochastic Oscillator | 68.60 | 71.43 |
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.